What is the safest muscle relaxant for a 65-year-old patient with atrial fibrillation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safest Muscle Relaxant in 65-Year-Old with Atrial Fibrillation

Tizanidine is the safest muscle relaxant for a 65-year-old patient with atrial fibrillation, as it carries significantly lower risks of injury and delirium compared to baclofen, while traditional "muscle relaxants" like cyclobenzaprine should be avoided due to strong anticholinergic effects that are particularly dangerous in older adults.

Primary Recommendation

The most recent and highest quality evidence directly addressing this question comes from a 2023 retrospective cohort study of over 18,000 older adults (≥65 years) comparing baclofen versus tizanidine 1. This study found that baclofen was associated with a 54% increased risk of injury (HR=1.54) and a 233% increased risk of delirium (HR=3.33) compared to tizanidine when used for musculoskeletal pain 1.

Why Traditional "Muscle Relaxants" Are Not Appropriate

The 2021 Mayo Clinic guidelines on polypharmacy management explicitly identify cyclobenzaprine as a strongly anticholinergic medication that should be deprescribed in older adults 2. These anticholinergic medications cause:

  • Vision problems
  • Urinary retention
  • Constipation
  • Cognitive decline
  • Increased fall risk
  • Delirium episodes
  • Emergency department visits

The 2020 JAGS guidelines reinforce this, stating that traditional muscle relaxants (methocarbamol, carisoprodol, chlorzoxazone, metaxalone, and cyclobenzaprine) "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" and are "not favored for chronic pain" in older adults due to adverse effect potential 3.

Specific Concerns with Atrial Fibrillation

While the evidence doesn't show direct cardiac interactions between muscle relaxants and atrial fibrillation, the anticholinergic burden from drugs like cyclobenzaprine can:

  • Worsen cognitive function (critical for medication adherence in AFib patients on anticoagulation)
  • Increase fall risk (catastrophic when combined with anticoagulation for AFib)
  • Cause confusion that may mask or complicate AFib symptom recognition

Clinical Algorithm

For acute musculoskeletal pain (<2 weeks):

  • Use tizanidine at the lowest effective dose
  • Start with 2mg at bedtime, titrate cautiously
  • Monitor for hypotension and sedation

For chronic pain:

  • Avoid muscle relaxants entirely 3
  • Consider duloxetine or pregabalin for chronic musculoskeletal conditions 3
  • Address underlying pain mechanisms rather than relying on muscle relaxants

Critical Pitfalls to Avoid

  1. Never prescribe cyclobenzaprine - it has the worst anticholinergic profile and no proven efficacy in chronic pain 3, 2

  2. Avoid carisoprodol - significant potential for dependence and greatest toxicity profile 4

  3. If baclofen must be used (e.g., for spasticity rather than pain), recognize the substantially higher delirium and injury risk 1 and monitor extremely closely

  4. Don't assume "muscle relaxants" actually relax muscles - they are sedatives with anticholinergic properties, not true muscle relaxants 3

References

Research

Safety of baclofen versus tizanidine for older adults with musculoskeletal pain.

Journal of the American Geriatrics Society, 2023

Guideline

polypharmacy management in older patients.

Mayo Clinic Proceedings, 2021

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Research

A review of three commonly prescribed skeletal muscle relaxants.

Journal of back and musculoskeletal rehabilitation, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.